GG
Gregg Gilbert Truist Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
DHT Holdings
DHT
$1.96B
| $12.17 | $17 |
40%
upside
| Buy |
16 Feb ‘24
1 year ago |
|
2
Collegium Pharmaceutical
COLL
$1.19B
| $37.97 | $37 |
3%
downside
| Buy |
4 Jan ‘24
1 year ago |
|
3
Bristol-Myers Squibb
BMY
$96.1B
| $47.23 | $84 |
78%
upside
| Buy |
15 Sep ‘23
2 years ago |
|
4
Eli Lilly
LLY
$662B
| $750.61 | $525 |
30%
downside
| Buy |
20 Jul ‘23
2 years ago |
|
5
Evolus
EOLS
$492M
| $7.39 | $13 |
76%
upside
| Buy |
4 Mar ‘22
3 years ago |
|
6
Merck
MRK
$211B
| $84.61 | $93 |
10%
upside
| Buy |
7 Jun ‘21
4 years ago |
|
7
Organon & Co
OGN
$2.72B
| $10.37 | $48 |
363%
upside
| Buy |
2 Jun ‘21
4 years ago |
|
8
Arcutis Biotherapeutics
ARQT
$2.15B
| $17.93 | $48 |
168%
upside
| Buy |
2 Feb ‘21
4 years ago |
|
9
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $1.35 | $26 |
1,826%
upside
| Buy |
17 Apr ‘20
5 years ago |
|
10
Matinas BioPharma
MTNB
$9.27M
| $1.64 | $150 |
9,046%
upside
| Buy |
24 Jan ‘20
5 years ago |
|